recombinant anti-PD-L1/PD-L2 protein (Beijing Pomona Biological Technology)

N/A

Report date: 2025/03/20 09:38:27

Base Information

Drug Namerecombinant anti-PD-L1/PD-L2 protein (Beijing Pomona Biological Technology)
Drug Alias Namedual PD-L1 checkpoint inhibitor/PD-L2 checkpoint inhibitor (Beijing Pomona Biological Technology)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionProgrammed death-ligand 1 blockersProgrammed death-ligand 2 inhibitors
TargetsProgrammed death-ligand 2Programmed death-ligand 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Pomona Biological Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Pomona Biological Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A